BRIEF published on 02/23/2026 at 15:24, 6 months 22 days ago Vanguard Group Discloses Position in Just Group plc Securities Disclosure Takeover Code Vanguard Group Just Group
BRIEF published on 02/23/2026 at 15:23, 6 months 22 days ago The Vanguard Group Discloses Position in LondonMetric Property plc Shares Disclosure Takeover Code Vanguard LondonMetric
PRESS RELEASE published on 02/23/2026 at 15:23, 6 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc with 30,156,894 securities purchased at 12.19 GBP per unit on 20 Feb 2026 The Vanguard Group, Inc. Ownership Disclosure Securities Purchase Beazley Plc GBP 12.19
BRIEF published on 02/23/2026 at 15:22, 6 months 22 days ago The Vanguard Group Discloses Position on International Personal Finance Form 8.3 Takeover Code Securities Disclosure Vanguard Group International Personal Finance
BRIEF published on 02/23/2026 at 15:22, 6 months 22 days ago Vanguard Group Discloses Position in NCC Group plc Takeover Code Securities Disclosure Vanguard Group Share Transaction NCC Group
PRESS RELEASE published on 02/23/2026 at 15:21, 6 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. files Form 8.3 disclosing 2.51% ownership in Schroders plc on 20 Feb 2026. Purchase of 16,023 20p ordinary shares at 5.86 GBP per unit Form 8.3 Schroders Plc Vanguard Group Ownership Disclosure Share Purchase
PRESS RELEASE published on 02/23/2026 at 15:20, 6 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc as of 20 February 2026 through Form 8.3 filing Form 8.3 Disclosure Vanguard Group Spire Healthcare Stake
PRESS RELEASE published on 02/23/2026 at 15:20, 6 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc The Vanguard Group, Inc. discloses 1% ownership of Oxford Biomedica plc securities as of 20th Feb 2026. Details in Form 8.3 filing Form 8.3 Vanguard Group Ownership Disclosure Financial Securities Oxford Biomedica
PRESS RELEASE published on 02/23/2026 at 15:19, 6 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses ownership of 4.92% in Just Group plc's 10p ordinary securities. Form 8.3 filed under Takeover Code Rule 8.3 The Vanguard Group, Inc. Form 8.3 Takeover Code Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/23/2026 at 15:18, 6 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.29% stake in LondonMetric Property plc. Positions and dealings detailed as per Form 8.3 disclosure requirements LondonMetric Property Plc The Vanguard Group Financial Holdings Form 8.3 Disclosure Stock Transactions
Published on 09/18/2026 at 06:30, 2 hours 51 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 8 hours 26 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 8 hours 56 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 11 hours 6 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 09:03, 18 minutes ago LIBERO receives the Investment Excellence Award 2026
Published on 09/18/2026 at 09:00, 21 minutes ago Original-Research: ASMALLWORLD AG (von NuWays AG): BUY
Published on 09/18/2026 at 09:00, 21 minutes ago Original-Research: Swissnet AG (von NuWays AG): Under review
Published on 09/17/2026 at 17:40, 15 hours 41 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 15 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 2 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
